How the next generation of GLP-1 drugs could change lives.

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Learn more about GLP-1 pills and how they may be more convenient and cost-effective than the injections.

GLP-1 medications have been a life-changing tool to help people manage their blood sugar and lose weight. But the most popular forms of these medications have a big drawback: You have to inject ...

As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit ...

A ’nuanced’ look at the implications of weight-loss drugs ...

Jonah Hill's dramatic weight loss didn't just change his body, it noticeably altered his face, leaving behind a gaunt look ...

Novo Nordisk’s ‘There’s Only One Ozempic’ campaign is about reasserting the drugmaker’s brand name in an increasingly ...

With just a few months to go before Eli Lilly expects to launch its own oral GLP-1 obesity drug, Novo Nordisk is making the ...